EP0022762B1 - Indolizinderivate, Verfahren zu ihrer Herstellung sowie ihre therapeutische Verwendung - Google Patents
Indolizinderivate, Verfahren zu ihrer Herstellung sowie ihre therapeutische Verwendung Download PDFInfo
- Publication number
- EP0022762B1 EP0022762B1 EP80870035A EP80870035A EP0022762B1 EP 0022762 B1 EP0022762 B1 EP 0022762B1 EP 80870035 A EP80870035 A EP 80870035A EP 80870035 A EP80870035 A EP 80870035A EP 0022762 B1 EP0022762 B1 EP 0022762B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- indolizine
- methoxy
- bromine
- benzoyl
- chlorine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 0 Cc(cc1*)cc(*)c1O Chemical compound Cc(cc1*)cc(*)c1O 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Definitions
- indolizine derivatives of formula 1 useful in cardiovascular disorders which can be treated by potentiating the cardiovascular effects of catecholamines, for example disorders of the cerebral vascular system and the heart failure.
- in vitro tests were carried out in the absorption cuvette of a UV spectrophotometer as regards the inhibitory effect on xanthine oxidase and adenosine deaminase.
- in vivo tests were carried out in order to demonstrate the uricosuric action and the inhibitory effect on adenosine deaminase.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Claims (15)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7923599 | 1979-07-06 | ||
GB7923599 | 1979-07-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0022762A1 EP0022762A1 (de) | 1981-01-21 |
EP0022762B1 true EP0022762B1 (de) | 1981-11-25 |
Family
ID=10506339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP80870035A Expired EP0022762B1 (de) | 1979-07-06 | 1980-06-30 | Indolizinderivate, Verfahren zu ihrer Herstellung sowie ihre therapeutische Verwendung |
Country Status (24)
Country | Link |
---|---|
US (1) | US4400387A (de) |
EP (1) | EP0022762B1 (de) |
JP (1) | JPS5618979A (de) |
AR (1) | AR225314A1 (de) |
AT (1) | AT375078B (de) |
AU (1) | AU529725B2 (de) |
CA (1) | CA1153379A (de) |
DD (1) | DD151940A5 (de) |
DE (1) | DE3060097D1 (de) |
DK (1) | DK146962C (de) |
ES (1) | ES493139A0 (de) |
FI (1) | FI67217C (de) |
GR (1) | GR69280B (de) |
HU (1) | HU182151B (de) |
IE (1) | IE49994B1 (de) |
IN (1) | IN151594B (de) |
NO (1) | NO153496C (de) |
NZ (1) | NZ193926A (de) |
OA (1) | OA06563A (de) |
PL (1) | PL125597B1 (de) |
PT (1) | PT71424A (de) |
SU (1) | SU993817A3 (de) |
YU (1) | YU171880A (de) |
ZA (1) | ZA803434B (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103702A (en) * | 1999-05-24 | 2000-08-15 | Board Of Trustees Of The University Of Illinois | Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome |
AU6234000A (en) * | 1999-07-22 | 2001-02-13 | Supergen, Inc. | Methods for treating autoimmune diseases |
FR2805460A1 (fr) | 2000-02-25 | 2001-08-31 | Oreal | Compositions de teinture des fibres keratiniques contenant des derives d'indolizine cationiques et procede de teinture |
FR2838123B1 (fr) * | 2002-04-04 | 2005-06-10 | Sanofi Synthelabo | Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf |
JP4048166B2 (ja) * | 2002-11-18 | 2008-02-13 | 三井製糖株式会社 | 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料 |
FR2859997B1 (fr) * | 2003-09-18 | 2006-02-03 | Sanofi Synthelabo | Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant. |
AR051780A1 (es) * | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos |
FR2896247B1 (fr) | 2006-01-13 | 2008-02-29 | Sanofi Aventis Sa | Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique |
ES2429148T3 (es) * | 2009-03-31 | 2013-11-13 | Kissei Pharmaceutical Co., Ltd. | Derivado de indolizina y su utilización para fines médicos |
US20100261666A1 (en) * | 2009-04-14 | 2010-10-14 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for the treatment of myocardial dysfunction associated with sirs or sepsis |
EP2623505B1 (de) * | 2010-09-29 | 2015-07-29 | Kissei Pharmaceutical Co., Ltd. | (aza)indolizinderivate als inhibitoren der xanthinoxidase |
KR102109061B1 (ko) * | 2015-09-10 | 2020-05-11 | 쟝쑤 애텀 바이오사이언스 앤드 파머수티컬 컴퍼니 리미티드 | 고요산혈증 또는 통풍을 치료 또는 예방하는 화합물 |
CN108084186B (zh) * | 2016-11-16 | 2021-06-25 | 江苏新元素医药科技有限公司 | Urat1抑制剂及其应用 |
WO2018090921A1 (zh) | 2016-11-16 | 2018-05-24 | 江苏新元素医药科技有限公司 | Urat1抑制剂及其应用 |
CN108484600B (zh) * | 2017-05-26 | 2022-12-13 | 江苏新元素医药科技有限公司 | 促尿酸排泄的urat1抑制剂 |
CN114213331A (zh) * | 2017-05-26 | 2022-03-22 | 江苏新元素医药科技有限公司 | 一类urat1抑制剂及其应用 |
KR20200112908A (ko) * | 2018-01-19 | 2020-10-05 | 쑤저우 시노벤트 파마슈티칼즈 씨오., 엘티디. | 헤테로시클릭 화합물, 제조 방법 및 의약품에서의 이의 용도 |
CN110283167A (zh) * | 2018-11-14 | 2019-09-27 | 贵州省中国科学院天然产物化学重点实验室 | 一种抗心率失常药物布托普洛嗪的制备方法 |
WO2022169974A1 (en) | 2021-02-05 | 2022-08-11 | Nexys Therapeutics, Inc. | Inhibitors of urat1 and pharmaceutical uses thereof |
WO2023221078A1 (en) * | 2022-05-20 | 2023-11-23 | Jiangsu Atom Bioscience And Pharmaceutical Co., Ltd. | Solid forms of a compound for treating or preventing hyperuricemia or gout |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU430639A1 (ru) | 1972-06-05 | 1978-02-28 | Московский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.М.В.Ломоносова | Способ получени 1-пиридилиндолизинов |
GB1518443A (en) * | 1976-02-19 | 1978-07-19 | Labaz | Indolizine derivatives and process for preparing the same |
FI61030C (fi) | 1976-02-19 | 1982-05-10 | Sanofi Sa | Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat |
-
1980
- 1980-06-04 NZ NZ193926A patent/NZ193926A/en unknown
- 1980-06-09 ZA ZA00803434A patent/ZA803434B/xx unknown
- 1980-06-10 GR GR62170A patent/GR69280B/el unknown
- 1980-06-20 PT PT71424A patent/PT71424A/pt unknown
- 1980-06-20 AU AU59487/80A patent/AU529725B2/en not_active Ceased
- 1980-06-26 IN IN738/CAL/80A patent/IN151594B/en unknown
- 1980-06-30 DE DE8080870035T patent/DE3060097D1/de not_active Expired
- 1980-06-30 EP EP80870035A patent/EP0022762B1/de not_active Expired
- 1980-06-30 US US06/164,838 patent/US4400387A/en not_active Expired - Lifetime
- 1980-06-30 IE IE1349/80A patent/IE49994B1/en unknown
- 1980-07-01 YU YU01718/80A patent/YU171880A/xx unknown
- 1980-07-02 OA OA57151A patent/OA06563A/xx unknown
- 1980-07-02 AR AR281618A patent/AR225314A1/es active
- 1980-07-03 SU SU802942500A patent/SU993817A3/ru active
- 1980-07-04 HU HU801674A patent/HU182151B/hu not_active IP Right Cessation
- 1980-07-04 JP JP9216080A patent/JPS5618979A/ja active Pending
- 1980-07-04 ES ES493139A patent/ES493139A0/es active Granted
- 1980-07-04 DK DK291180A patent/DK146962C/da not_active IP Right Cessation
- 1980-07-04 DD DD80222415A patent/DD151940A5/de unknown
- 1980-07-04 CA CA000355421A patent/CA1153379A/en not_active Expired
- 1980-07-04 PL PL1980225479A patent/PL125597B1/pl unknown
- 1980-07-04 NO NO802015A patent/NO153496C/no unknown
- 1980-07-07 FI FI802165A patent/FI67217C/fi not_active IP Right Cessation
- 1980-07-07 AT AT0354380A patent/AT375078B/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DD151940A5 (de) | 1981-11-11 |
OA06563A (fr) | 1981-07-31 |
AU529725B2 (en) | 1983-06-16 |
YU171880A (en) | 1983-10-31 |
PL225479A1 (de) | 1981-10-30 |
FI67217C (fi) | 1985-02-11 |
PT71424A (en) | 1980-07-01 |
DK291180A (da) | 1981-01-07 |
HU182151B (en) | 1983-12-28 |
DK146962C (da) | 1984-08-06 |
GR69280B (de) | 1982-05-13 |
NO153496B (no) | 1985-12-23 |
IN151594B (de) | 1983-06-04 |
AR225314A1 (es) | 1982-03-15 |
JPS5618979A (en) | 1981-02-23 |
IE49994B1 (en) | 1986-01-22 |
DK146962B (da) | 1984-02-27 |
ES8105710A1 (es) | 1981-06-16 |
ATA354380A (de) | 1983-11-15 |
EP0022762A1 (de) | 1981-01-21 |
ES493139A0 (es) | 1981-06-16 |
ZA803434B (en) | 1981-05-27 |
DE3060097D1 (en) | 1982-01-28 |
AT375078B (de) | 1984-06-25 |
AU5948780A (en) | 1981-01-15 |
NO802015L (no) | 1981-01-07 |
FI802165A (fi) | 1981-01-07 |
CA1153379A (en) | 1983-09-06 |
NO153496C (no) | 1986-05-14 |
NZ193926A (en) | 1984-05-31 |
SU993817A3 (ru) | 1983-01-30 |
US4400387A (en) | 1983-08-23 |
FI67217B (fi) | 1984-10-31 |
IE801349L (en) | 1981-01-06 |
PL125597B1 (en) | 1983-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0022762B1 (de) | Indolizinderivate, Verfahren zu ihrer Herstellung sowie ihre therapeutische Verwendung | |
EP0463945B1 (de) | Chalkonderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten | |
BE851310A (fr) | Nouveaux derives de la tetrahydro-equinocandine b | |
EP0399856B1 (de) | Pteridin-4 (3H)-onen, Verfahren zu ihrer Herstellung und sie enthaltende Medikamente | |
LU86406A1 (fr) | Imidazoquinoleines antithrombogenes cardiotoniques | |
EP0252809A2 (de) | Nitrofuranderivate, ihre Herstellung und ihre therapeutische Verwendung | |
CH655114A5 (fr) | Derives de l'imidazotetrazinone, leur preparation et compositions pharmaceutiques les contenant. | |
FR2647676A1 (fr) | Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase | |
EP0709383B1 (de) | Diosmetin Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen | |
EP0021940B1 (de) | Aminoderivate von Benzothiazol, Verfahren zu ihrer Herstellung und ihre Anwendung in der Heilkunde | |
EP0200605A1 (de) | Nitrofuranderivate, ihre Herstellung und ihre Anwendung in der Therapie | |
JPH07116117B2 (ja) | キノン誘導体 | |
EP0463944A1 (de) | Acylbenzoxazolinone, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten | |
FR2600646A1 (fr) | Derives de la glycine | |
EP0094283B1 (de) | Arzneimittelform von Theophyllin mit verlängerter Wirkung | |
EP0136198B1 (de) | Triazolopyrimidinderivate, Verfahren zu ihrer Herstellung und ihre therapeutische Anwendung als Kardiotonika | |
EP0097636B1 (de) | Indolizinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
EP0536035A1 (de) | 1,8-Benzonaphthyridinderivate und antimikrobielle Zusammensetzungen | |
CH637650A5 (fr) | Procede de preparation d'un acide chromone carboxylique. | |
EP0043811B1 (de) | Indolonaphthyridine und ihre Verwendung als Arzneimittel | |
BE856403A (fr) | Derives d'imidazole-4-carboxamide 5-0-acyles, procede pour leur preparation et medicaments en contenant | |
EP0517590A1 (de) | Oxazolederivate, ihre Herstellung und sie enthaltende Zusammensetzungen | |
EP0269841B1 (de) | 1-Hydroxyalkylxanthine, Verfahren zu ihrer Herstellung und sie enthaltende Medikamente | |
EP1225883A1 (de) | Anti-ischämische verbindungen | |
LU80712A1 (fr) | Composes polyfluorohydroxyisopropyl carbostyriles tricycliques antihypertensifs,leur preparation et compositions pharmaceutiques les contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB IT LU NL SE |
|
17P | Request for examination filed |
Effective date: 19810202 |
|
ITF | It: translation for a ep patent filed |
Owner name: DE DOMINICIS & MAYER S.R.L. |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB IT LU NL SE |
|
REF | Corresponds to: |
Ref document number: 3060097 Country of ref document: DE Date of ref document: 19820128 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19820630 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Free format text: S.A. LABAZ-SANOFI N.V. |
|
ITPR | It: changes in ownership of a european patent |
Owner name: CAMBIO RAGIONE SOCIALE;S.A. LABAZ - SANOFI N.V. |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: CD |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 19890530 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19890608 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19890616 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19890619 Year of fee payment: 10 |
|
ITTA | It: last paid annual fee | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19890630 Year of fee payment: 10 Ref country code: GB Payment date: 19890630 Year of fee payment: 10 Ref country code: FR Payment date: 19890630 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 19890714 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Effective date: 19900630 Ref country code: GB Effective date: 19900630 Ref country code: CH Effective date: 19900630 Ref country code: BE Effective date: 19900630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19900701 |
|
BERE | Be: lapsed |
Owner name: S.A. LABAZ-SANOFI Effective date: 19900630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19910101 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Effective date: 19910228 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19910301 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
EUG | Se: european patent has lapsed |
Ref document number: 80870035.5 Effective date: 19910402 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |